Emmaus Life Sciences, Inc. EMMA
0.04 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
0.03 Day range 0.03
0.008 52-week range 0.0879
- YTD
- +170.77%
- 1 year
- +278.49%
- Market cap
- 2.47M
- EPS (ttm)
- -0.09
- YTD return
- +170.77%
- 1-year return
- +278.49%
- Volume
- 25.86K
- Avg volume
- 122.51K
- Open
- 0.03
- Previous close
- 0.0352
- Day's range
- 0.03 – 0.03
- 52-week range
- 0.008 – 0.0879
- Earnings date
- Jul 2, 2024
2Y +0.0081 (+29.89%)
Next earnings
Jul 2, 2024
Expected Jul 2, 2024. Consensus EPS estimate 0.00.
Financials — quick view
EMMA Revenue — quarterly 10.76M
EMMA Net income — quarterly -1.48M
EMMA EPS — quarterly -0.03
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 19, 2024 | Sep 1, 2024 | 0.00 | -0.01 | — | — |
| Sep 10, 2024 | Mar 1, 2024 | 0.00 | -0.07 | — | — |
| Sep 10, 2024 | Jun 1, 2024 | 0.00 | -0.03 | — | — |
| Jul 2, 2024 | Dec 1, 2023 | 0.00 | — | — | — |
| Nov 13, 2023 | Sep 1, 2023 | 0.00 | -0.01 | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | -0.03 | — | — |
News
Emmaus Life Sciences Announces Agreement for Evaluation of L-glutamine for Pancreatic Cancer 
Emmaus Life Sciences Reports Quarterly Financial Results 
Emmaus Life Sciences Reports Quarterly Financial Results 
Emmaus Life Sciences Reports Quarterly Financial Results 
Emmaus Life Sciences Reports Annual Financial Results 
Emmaus Life Sciences Announces Strategic Transaction 
Emmaus Life Sciences Reports Quarterly Financial Results 
Emmaus Life Sciences Reports Quarterly Financial Results 
Emmaus Life Sciences Receives FDA Approval for Endari® Label Enhancements 
Emmaus Life Sciences Reports Quarterly Financial Results
Your note
Sign in to keep a note on EMMA — it syncs with the Stock Master app.